Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Global Oncolytic Virus Therapy Market Size |Share|Outlook|Forecast to 2026

(, October 25, 2019 ) Market Overview

An oncolytic virus is a genetically engineered or naturally occurring virus that can imitate in selected terms and kill cancer cells without harming the normal tissues. Oncolytic Virus therapy is a new therapeutic approach for treating cancer and shown promising results globally.

Market Dynamics

The rising prevalence of cancer cases and increasing development of cancer-treating therapies such as an oncolytic virus is driving the market growth globally.

Technological developments such as natural killer cells and use of combination therapies are also driving the market growth. Further ongoing development of virus therapies globally, which are in the pipeline will further enhance the growth of oncolytic virus therapy market in the forecast period.

The immune reaction to the virus based therapies by repeated administration of therapeutics for treating cancer is a critical restraint that hampering market growth.

The high cost of oncolytic virus therapy is further affecting market growth, especially in developing countries.

Market Segmentation

Global Oncolytic Virus Therapy Market is segmented by application type, by drug class, and therapy type.

By application, the market is segmented into Prostate cancer, Melanoma, Ovarian Cancer, Breast Cancer, and others. Melanoma is accounted for the largest share as most of the cancer therapies are developed for Melanoma cancers. They are increasing prostate cancer cases also leading to a steady growth rate in prostate cancer therapies in recent years.

By Drug class the market is segmented into Onyx-15, Talimogene laherparepvec, Reolysin, RIGVIR. Talimogene laherparepvec is the most significant drug class that accounted for a significant share in the market and is mainly due to its large penetration in cancer treatment.

Geographical Share

By Geography the market is segmented into North America, South America, Europe, Asia Pacific and rest of the World. North America is the leading market globally and is mainly due to increased cancer cases associated with hectic lifestyles. Well-developed healthcare infrastructure is further supported by the growth in the region.

Market Key Companies

Oncolytic Virus Therapy is highly concentrated among a few key players such as Amgen, Shanghai Sunway Biotech Co. Ltd, and RIGVIR. Companies in the industry operate on low-profit margins, which is likely to worsen further during the forecast period. Industry players are focusing on implementing inorganic growth strategies to expand their presence in the market.

Request Customization:

Download free sample:

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at Data M Intelligence


Tel: +1 877 441 4866


DataM Intelligence

Sai Kiran

+1 877 441 4866

Source: EmailWire.Com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News

[CaRP] XML error: Mismatched tag at line 14 - This appears to be an HTML webpage, not a feed. is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC